Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
about
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLEmerging risk biomarkers in cardiovascular diseases and disordersApolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanismA hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins.Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.The reverse cholesterol transport pathway improves understanding of genetic networks for fat deposition and muscle growth in beef cattleSerum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiologyRole of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.Absorption and lipoprotein transport of sphingomyelin.Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.PLTP is present in the nucleus, and its nuclear export is CRM1-dependentNative and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.Lipoproteins, cholesterol homeostasis and cardiac health.Free cholesterol determines reassembled high-density lipoprotein phospholipid phase structure and stability.PC-TP/StARD2: Of membranes and metabolism.Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo.Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes.The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques.Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDL.Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease.Detangling the evolutionary developmental integration of dentate jaws: evidence that a p63 gene network regulates odontogenesis exclusive of mandible morphogenesis.Distribution of diacylglycerols among plasma lipoproteins in control subjects and in patients with non-insulin-dependent diabetes.Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteinsUnravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within
P2860
Q26801507-6FDDA519-E04E-4247-8FCF-59E832C4D860Q28081614-F0E3C455-817C-43DB-BC85-7C4BCFD79411Q28829054-7C4AC7F1-78D3-452B-B23B-F7BE3C278542Q31575347-159AD2F6-D573-49A4-BA1E-32D6ECBC67D2Q33714941-094E13DB-7898-478F-A6ED-052360C47D63Q33769501-66224FCB-AF66-4AC2-BB9A-36F8C7015B6BQ33907867-BA862A9B-FCD8-47EC-9622-186C527CB2BBQ34076399-F0195A05-FA02-47C1-80C8-F6462464BA38Q34656954-34EE9623-09E3-46A3-9FEE-AFA3EEB2B74FQ34657972-1986CC98-0149-402D-8524-9CDD27F8578AQ35341853-C09A4371-8B2D-4418-AA06-46545EB5A78EQ36298122-0A891EA3-1BE7-4185-848F-CB0D25CDE4C3Q37155515-7FD7F0E8-A87C-4209-9B55-DF5B6C099E7EQ37217609-7DE8D614-E62B-4447-9599-59594B301FE2Q37397956-D598EDCA-5D72-480A-9B45-926CED99D7E1Q37544267-661CED27-6DFF-4125-A374-C86FE5D03CFAQ37646548-09561E16-D775-4BCA-A43E-D3CC72095DC0Q37719141-CE41A18B-7D14-48E3-8BEB-0FC9A9D78F82Q38857612-55E546E0-ABC4-4AF7-9D98-69A716999D49Q39422967-2B81E6CE-E4CE-40AA-8B26-BEC6373446B6Q41645503-98FB3F64-EDBB-43B0-B38C-EF99E62001BAQ41964030-1AE0159B-4641-4716-AC26-773FEF7FF769Q42727368-3166299C-647E-4E7D-B9F1-9B52185E981FQ46493757-1C3456A4-5122-4CE0-BE2F-D30A1F929788Q48347562-B299A901-E5FC-441C-8809-B96E8957B965Q50475403-022F4022-7B9B-47C3-9A53-AB7BEB92A932Q52569099-AF902F9A-AB28-4260-85FA-B9ED8115A9D5Q53579311-DC4D1E8A-D500-41AC-B81A-99A443AEC040Q57123755-F630D0F1-6203-40A0-81C8-9ACE8782AF9AQ57176950-1078E854-786F-44C1-BFDD-9FDBC9FFE31B
P2860
Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
@en
type
label
Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
@en
prefLabel
Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
@en
P2093
P921
P356
P1433
P1476
Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
@en
P2093
P304
P356
10.1021/BI962776B
P407
P577
1997-03-01T00:00:00Z